Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: MYF002
MIFTS: 43

Myofascial Pain Syndrome

Categories: Muscle diseases
Genes Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Myofascial Pain Syndrome

About this section

MalaCards integrated aliases for Myofascial Pain Syndrome:

Name: Myofascial Pain Syndrome 12 15 17
Myofascial Pain Syndromes 45 74
Myofascial Pain Dysfunction Syndrome 56
Fibromyalgia 74

Classifications:

MalaCards categories:
Anatomical: Muscle diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:431
MeSH 45 D009209
Sources

Summaries for Myofascial Pain Syndrome

About this section
MalaCards based summary : Myofascial Pain Syndrome, also known as myofascial pain syndromes, is related to fibromyalgia and chronic fatigue syndrome, and has symptoms including muscle weakness, fatigue and myoclonus. An important gene associated with Myofascial Pain Syndrome is POMC (Proopiomelanocortin). The drugs Etoricoxib and Ethanol have been mentioned in the context of this disorder. Affiliated tissues include brain, breast and heart.

Wikipedia : 77 Myofascial pain syndrome (MPS), also known as chronic myofascial pain (CMP), is a syndrome characterized... more...

Sources

Related Diseases for Myofascial Pain Syndrome

About this section

Diseases related to Myofascial Pain Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 43)
# Related Disease Score Top Affiliating Genes
1 fibromyalgia 11.9
2 chronic fatigue syndrome 10.4
3 bruxism 10.1
4 childhood disintegrative disease 10.1 BDNF POMC
5 breast cancer 10.1
6 reflex sympathetic dystrophy 10.1
7 anxiety 10.1
8 algoneurodystrophy 10.1
9 pain - chronic 10.1
10 mental depression 10.0 BDNF POMC
11 drug dependence 10.0 BDNF POMC
12 tendinosis 10.0 BDNF PDGFRB
13 eating disorder 10.0 BDNF POMC
14 mucolipidosis iii alpha/beta 10.0
15 joint disorders 10.0
16 mucolipidosis 10.0
17 pulpitis 10.0
18 glossopharyngeal neuralgia 10.0
19 substance dependence 10.0 BDNF POMC
20 disease of mental health 9.9 BDNF POMC
21 neurodermatitis 9.9 POMC TAC1
22 temporal arteritis 9.9
23 trigeminal neuralgia 9.9
24 fibrosclerosis, multifocal 9.9
25 angioma, tufted 9.9
26 hemangioma 9.9
27 osteoarthritis 9.9
28 bursitis 9.9
29 adenocarcinoma 9.9
30 intramuscular hemangioma 9.9
31 neuropathy 9.9
32 retroperitoneal fibrosis 9.9
33 depression 9.9
34 headache 9.9
35 pain agnosia 9.9 POMC TAC1
36 epicondylitis 9.9 NDUFB8 TAC1
37 agnosia 9.9 POMC TAC1
38 mood disorder 9.9 BDNF POMC
39 paine syndrome 9.8 BDNF TAC1
40 brachial plexus lesion 9.8 BDNF TAC1
41 interstitial cystitis 9.8 BDNF TAC1
42 anorexia nervosa 9.8 BDNF POMC
43 specific developmental disorder 9.6 BDNF POMC TAC1

Graphical network of the top 20 diseases related to Myofascial Pain Syndrome:



Diseases related to Myofascial Pain Syndrome
Sources

Symptoms & Phenotypes for Myofascial Pain Syndrome

About this section

UMLS symptoms related to Myofascial Pain Syndrome:


muscle weakness, fatigue, myoclonus, back pain, myalgia, pain, torticollis, chronic pain, sciatica, muscle cramp, muscle rigidity, muscle spasticity, myofascial trigger point pain
Sources

Drugs & Therapeutics for Myofascial Pain Syndrome

About this section

Drugs for Myofascial Pain Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 357)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
2
Ethanol Approved Phase 4,Phase 3,Phase 2,Not Applicable 64-17-5 702
3
Naltrexone Approved, Investigational, Vet_approved Phase 4,Phase 2,Not Applicable 16590-41-3 5360515
4
Levomilnacipran Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 96847-54-0
5
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-41-2 439260
6
Benzocaine Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 94-09-7, 1994-09-7 2337
7
Milnacipran Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 92623-85-3 65833
8
tannic acid Approved Phase 4,Phase 1,Phase 2,Not Applicable 1401-55-4
9
Amitriptyline Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 50-48-6 2160
10
Cyclobenzaprine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 303-53-7 2895
11
Dinoprostone Approved Phase 4 363-24-6 5280360
12
Gabapentin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 60142-96-3 3446
13
Perphenazine Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 58-39-9 4748
14
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 148553-50-8 5486971
15
Acetylcholine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-84-3 187
16
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 137-58-6 3676
17
Dopamine Approved Phase 4,Phase 3,Phase 2,Not Applicable 62-31-7, 51-61-6 681
18
Acetaminophen Approved Phase 4,Phase 3,Phase 2,Not Applicable 103-90-2 1983
19
Tramadol Approved, Investigational Phase 4,Phase 3,Phase 2 27203-92-5 33741
20
Naloxone Approved, Vet_approved Phase 4,Phase 2,Phase 1,Not Applicable 465-65-6 5284596
21
Paroxetine Approved, Investigational Phase 4,Phase 1,Phase 2 61869-08-7 43815
22
Trazodone Approved, Investigational Phase 4 19794-93-5 5533
23
Fluoxetine Approved, Vet_approved Phase 4,Phase 3,Phase 2 54910-89-3 3386
24
Eszopiclone Approved, Investigational Phase 4 138729-47-2 969472
25
Colchicine Approved Phase 4 64-86-8 6167 2833
26
Modafinil Approved, Investigational Phase 4,Phase 3 68693-11-8 4236
27
Hydrocortisone Approved, Vet_approved Phase 4,Early Phase 1,Not Applicable 50-23-7 5754
28
Hydrocortisone acetate Approved, Vet_approved Phase 4,Early Phase 1,Not Applicable 50-03-3
29
Granisetron Approved, Investigational Phase 4 109889-09-0 3510
30
Deferasirox Approved, Investigational Phase 4 201530-41-8 5493381
31
Iron Approved, Experimental Phase 4,Phase 3,Phase 2 7439-89-6, 15438-31-0 23925 27284
32
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 1 9004-61-9 53477741
33
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
34
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2 51-45-6 774
35
Sodium oxybate Approved Phase 4,Phase 3,Phase 2 502-85-2 5360545
36
Flunarizine Approved Phase 4 52468-60-7 941361
37
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
38
Suvorexant Approved, Investigational Phase 4 1030377-33-3
39
Promethazine Approved, Investigational Phase 4 60-87-7 4927
40
Diphenhydramine Approved, Investigational Phase 4 147-24-0, 58-73-1 3100
41
Buprenorphine Approved, Illicit, Investigational, Vet_approved Phase 4 52485-79-7 40400 644073
42
Ergocalciferol Approved, Nutraceutical Phase 4 50-14-6 5280793
43
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4 1406-16-2
44
Calcium Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 7440-70-2 271
45
Glutamic Acid Approved, Nutraceutical Phase 4,Not Applicable 56-86-0 33032
46
Vitamin D3 Approved, Nutraceutical Phase 4 67-97-0 5280795 6221
47 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
48 Anti-Inflammatory Agents Phase 4,Phase 2,Phase 1,Not Applicable,Early Phase 1
49 Cyclooxygenase Inhibitors Phase 4,Phase 2,Phase 1,Not Applicable
50 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 916)
# Name Status NCT ID Phase Drugs
1 Study Assessing the Efficacy of Etoricoxib in Female Patients With Fibromyalgia Unknown status NCT00755521 Phase 4 etoricoxib
2 Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism? Unknown status NCT02806440 Phase 4 Low dose naltrexone;Placebo
3 Study of Fibromyalgia Treated With Milnacipran Unknown status NCT01125423 Phase 4 Milnacipran
4 Cyclobenzaprine Extended Release (ER) for Fibromyalgia Unknown status NCT01041495 Phase 4 cyclobenzaprine ER (AMRIX);placebo
5 The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain Unknown status NCT01417923 Phase 4 vitamin D
6 Study to Evaluate the Efficacy of Milnacipran in the Treatment of Pain Due to Osteoarthritis Unknown status NCT01329406 Phase 4 Milnacipran;Placebo
7 The Impact of Perioperative Gabapentin on Chronic Groin Pain After Inguinal Hernia Repair Unknown status NCT02419443 Phase 4 Gabapentin;Placebo
8 Quetiapine Compared With Placebo in the Management of Fibromyalgia Completed NCT01458964 Phase 4 Quetiapine
9 Effect of Milnacipran on Pain in Fibromyalgia Completed NCT01288807 Phase 4 Milnacipram
10 Valuation of Efficacy and Safety of Vitamin D3 Use in 80 Women Diagnosed With Fibromyalgia. Using FIQ Score and VAS. Completed NCT03369379 Phase 4 D3 Vitamin
11 Pool-based Exercise in Fibromyalgia Management Completed NCT00550641 Phase 4
12 Comparative Efficacy and Tolerability of Quetiapine XR and Amitriptyline in the Treatment of Fibromyalgia Completed NCT00766350 Phase 4 amitriptyline;quetiapine
13 Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome Completed NCT00610610 Phase 4 Paroxetine CR;Placebo
14 Quetiapine (Seroquel XR) for the Treatment of Fibromyalgia: a Clinical and Mechanistic Pilot Study Completed NCT00983320 Phase 4 quetiapine;placebo
15 Strengthening Exercises for Fibromyalgia Completed NCT02063750 Phase 4
16 A Pilot Study on the Use of Nociceptive Flexion Reflex for Fibromyalgia Completed NCT00965601 Phase 4
17 Trazodone and Its Augmentation With Pregabalin in the Treatment of Fibromyalgia Completed NCT00791739 Phase 4 trazodone, pregabalin
18 Combining N-of-1 Trials to Assess Fibromyalgia Treatments Completed NCT00000428 Phase 4 Amitriptyline;Amitriptyline plus Fluoxitine
19 Discomfort and Psychosocial Difficulties in Fibromyalgia Completed NCT02078791 Phase 4 Botox infiltration
20 Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia Completed NCT01014585 Phase 4 Placebo;Milnacipran
21 Drug and Talk Therapy for Fibromyalgia Completed NCT01038323 Phase 4 Educational with milnacipran
22 Adolescent Fibromyalgia Study Completed NCT01020474 Phase 4 placebo;pregabalin (Lyrica)
23 Heart Rate Variability in Fibromyalgia - Effects of Strengthening Exercises Completed NCT02004405 Phase 4
24 Treatment of Myofascial Pain Syndrome With Lidocaine Injection and Physical Therapy. Completed NCT01250184 Phase 4 Lidocaine injection
25 Fixed Versus Flexible Dosing of Pregabalin in Patients With Fibromyalgia Completed NCT01226667 Phase 4 Pregabalin
26 Ai Chi Versus Stretching in Fibromyalgia Management Completed NCT00600574 Phase 4
27 A Study for Adult Patients With Fibromyalgia Completed NCT00965081 Phase 4 Duloxetine;Placebo
28 A Study to Evaluate the Effects of Milnacipran on Pain Processing and Functional MRI in Patients With Fibromyalgia Completed NCT01173055 Phase 4 milnacipran;Placebo
29 The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia Completed NCT01234675 Phase 4 Milnacipran;Milnacipran
30 Eszopiclone in the Treatment of Insomnia and Fibromyalgia Completed NCT00392041 Phase 4 Eszopiclone;placebo
31 Pregabalin In Adolescent Patients With Fibromyalgia Completed NCT01020526 Phase 4 pregabalin
32 An Efficacy Study of Combination of Tramadol and Acetaminophen Tablets in the Treatment of Participants With Fibromyalgia Pain Completed NCT00766675 Phase 4 Tramadol hydrochloride;Acetaminophen
33 Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia Completed NCT01077375 Phase 4 Placebo;Milnacipran
34 A Study Comparing Duloxetine and Placebo in the Treatment of Fibromyalgia Completed NCT00673452 Phase 4 duloxetine hydrochloride;placebo
35 EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes Completed NCT00272532 Phase 4 Thiocolchicoside
36 An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue Completed NCT00678691 Phase 4 armodafinil;placebo
37 A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia Syndrome Completed NCT00675896 Phase 4 Quetiapine Fumarate Sustained Release;Placebo
38 Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome Completed NCT00241215 Phase 4 Botulinum toxin serotype A
39 Pharmacokinetics of Two Formulation of Pregabalin Completed NCT03712475 Phase 4 Pregabalin
40 Patient Self-administration of Cortisol for Cortisol-responding Disorders in Men and Women Over the Age of 17 Completed NCT03558971 Phase 4 Cortisol
41 Milnacipran for Chronic Pain in Knee Osteoarthritis Completed NCT01510457 Phase 4 Milnacipran;Placebo
42 Comparison of the Efficacy of Duloxetine With Placebo in Patients With Chronic Low Back Pain With a Radicular Component Completed NCT01166048 Phase 4 Duloxetine;Duloxetine
43 Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome Completed NCT01071044 Phase 4 Lisdexamfetamine Dimesylate;Placebo "30, 50 or 70 mg"
44 Study on the Effect of Granisetron on Myofascial Pain in the Orofacial Muscles Completed NCT02230371 Phase 4 Granisetron;Control (placebo)
45 Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload Completed NCT00673608 Phase 4 deferasirox
46 A Double Blind Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for Temporomandibular Joint (TMJ) Dysfunction Completed NCT01524913 Phase 4 Hyaluronic acid;Corticosteroid;Lactated Ringers
47 Neurologic Signatures of Chronic Pain Disorders Recruiting NCT02747940 Phase 4 flunarizine and/or pregabalin
48 Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty Enrolling by invitation NCT03271151 Phase 4 Cymbalta
49 Using Saline for Myofascial Pain Syndromes (USAMPS) Terminated NCT02120261 Phase 4
50 Influence of Transcranial Direct Current Stimulation of the Primary Motor Cortex on Pain Sensation in Patients Suffering From Fibromyalgia Syndrome Terminated NCT01261650 Phase 4

Search NIH Clinical Center for Myofascial Pain Syndrome

Cochrane evidence based reviews: myofascial pain syndromes

Sources

Genetic Tests for Myofascial Pain Syndrome

About this section
Sources

Anatomical Context for Myofascial Pain Syndrome

About this section

MalaCards organs/tissues related to Myofascial Pain Syndrome:

42
Brain, Breast, Heart, Testes, Liver, Cortex, Spinal Cord
Sources

Publications for Myofascial Pain Syndrome

About this section

Articles related to Myofascial Pain Syndrome:

(show top 50) (show all 306)
# Title Authors Year
1
Feasibility of a Support Vector Machine Classifier for Myofascial Pain Syndrome: Diagnostic Case-Control Study. ( 30614553 )
2019
2
Evidence for kinesio taping in management of myofascial pain syndrome: a systematic review and meta-analysis. ( 30712369 )
2019
3
Local Anesthetic Injections for the Short-Term Treatment of Head and Neck Myofascial Pain Syndrome: A Systematic Review with Meta-Analysis. ( 30893405 )
2019
4
Pathophysiology and Management of Abdominal Myofascial Pain Syndrome (AMPS): A Three-Year Prospective Audit of a Management Pathway in 120 Patients. ( 29444277 )
2018
5
The Distinction of Hot Herbal Compress, Hot Compress, and Topical Diclofenac as Myofascial Pain Syndrome Treatment. ( 29405762 )
2018
6
Concurrent validation of a pressure pain threshold scale for individuals with myofascial pain syndrome and fibromyalgia. ( 29456445 )
2018
7
Challenging the Cinderella Hypothesis: A New Model for the Role of the Motor Unit Recruitment Pattern in the Pathogenesis of Myofascial Pain Syndrome in Postural Muscles. ( 29944114 )
2018
8
The Effectiveness of Dry Needling and Exercise Therapy in Patients with Dizziness Caused By Cervical Myofascial Pain Syndrome; Prospective Randomized Clinical Study. ( 29718418 )
2018
9
Combination of exercise and acupuncture vs acupuncture alone for treatment of myofascial pain syndrome: A randomized clinical trial. ( 29746993 )
2018
10
Prevalence of myofascial pain syndrome in patients with incurable cancer. ( 29861227 )
2018
11
Methodological Issues on the Accuracy and Precision of Clinical Examination in the Diagnosis of Myofascial Pain Syndrome. ( 29788387 )
2018
12
Reply to "Clinical Examination in the Diagnosis of Myofascial Pain Syndrome; Methodological Issues on Validity and Reliability". ( 29788501 )
2018
13
Quantitative Ultrasound Using Texture Analysis of Myofascial Pain Syndrome in the Trapezius. ( 29717675 )
2018
14
Comparision of the effectiveness of ESWT and ultrasound treatments in myofascial pain syndrome: randomized, sham-controlled study. ( 29581669 )
2018
15
Fibromyalgia and myofascial pain syndrome: Two sides of the same coin? A scoping review to determine the lexicon of the current diagnostic criteria. ( 30350334 )
2018
16
A comparison of the clinical manifestation and pathophysiology of myofascial pain syndrome and fibromyalgia: implications for differential diagnosis and management. ( 30270926 )
2018
17
Comparison of ozone and lidocaine injection efficacy vs dry needling in myofascial pain syndrome patients. ( 29988746 )
2018
18
High- versus low-energy extracorporeal shock-wave therapy for myofascial pain syndrome of upper trapezius: A prospective randomized single blinded pilot study. ( 29995794 )
2018
19
Comparative study of shockwave therapy and low-level laser therapy effects in patients with myofascial pain syndrome of the trapezius. ( 30171341 )
2018
20
Safety and Efficacy of PrabotulinumtoxinA (Nabota®) Injection for Cervical and Shoulder Girdle Myofascial Pain Syndrome: A Pilot Study. ( 30177597 )
2018
21
Does improvement towards a normal cervical sagittal configuration aid in the management of cervical myofascial pain syndrome: a 1- year randomized controlled trial. ( 30419868 )
2018
22
Insights About the Neuroplasticity State on the Effect of Intramuscular Electrical Stimulation in Pain and Disability Associated With Chronic Myofascial Pain Syndrome (MPS): A Double-Blind, Randomized, Sham-Controlled Trial. ( 30459575 )
2018
23
Does kinesiotaping increase the efficacy of lidocaine injection in myofascial pain syndrome treatment? A randomized controlled study. ( 30507559 )
2018
24
Clinical features and myofascial pain syndrome in older adults with knee osteoarthritis by sex and age distribution: A cross-sectional study. ( 30528723 )
2018
25
Change in muscle hardness after trigger point injection and physiotherapy for myofascial pain syndrome. ( 30568046 )
2018
26
Effectiveness of Ultrasound Therapy on Myofascial Pain Syndrome of the Upper Trapezius: Randomized, Single-Blind, Placebo-Controlled Study. ( 30874250 )
2018
27
Comparision of two different dry-needling techniques in the treatment of myofascial pain syndrome. ( 28467572 )
2017
28
Reliability of assessment of upper trapezius morphology, its mechanical properties and blood flow in female patients with myofascial pain syndrome using ultrasonography. ( 28167187 )
2017
29
Acupuncture for Myofascial Pain Syndrome: A Network Meta-Analysis of 33 Randomized Controlled Trials. ( 28934793 )
2017
30
Far-infrared ray patches relieve pain and improve skin sensitivity in myofascial pain syndrome: A double-blind randomized controlled study. ( 29154057 )
2017
31
Extracorporeal Shock Wave Therapy Versus Trigger Point Injection in the Treatment of Myofascial Pain Syndrome in the Quadratus Lumborum. ( 28971042 )
2017
32
Assess pain intensity using photoplethysmography signal in chronic myofascial pain syndrome. ( 28502104 )
2017
33
Increased Risk of Myofascial Pain Syndrome Among Patients with Insomnia. ( 28339643 )
2017
34
A Multimodal Approach for Myofascial Pain Syndrome: A Prospective Study. ( 28739020 )
2017
35
Effect of dry needling on myofascial pain syndrome of the quadratus femoris: A case report. ( 28922048 )
2017
36
Comparison of the Efficiency of Ultrasound-Guided Injections of the Rhomboid Major and Trapezius Muscles in Myofascial Pain Syndrome: A Prospective Randomized Controlled Double-blind Study. ( 29048132 )
2017
37
Manual acupuncture for myofascial pain syndrome: a systematic review and meta-analysis. ( 28115321 )
2017
38
The effectiveness of Kinesio Taping on pain and disability in cervical myofascial pain syndrome. ( 28343625 )
2017
39
The Possible Role of Meditation in Myofascial Pain Syndrome: A New Hypothesis. ( 28503039 )
2017
40
Effectiveness of ultrasound therapy for myofascial pain syndrome: a systematic review and meta-analysis. ( 28331357 )
2017
41
Quantitative Ultrasound Assessment of Myofascial Pain Syndrome Affecting the Trapezius: A Reliability Study. ( 28670779 )
2017
42
Cutaneous silent period in myofascial pain syndrome. ( 28877555 )
2017
43
Characteristics of Myofascial Pain Syndrome of the Infraspinatus Muscle. ( 28971041 )
2017
44
Correction: Idiopathic Retroperitoneal Fibrosis With Myofascial Pain Syndrome: A Case Report. ( 29201835 )
2017
45
Corticospinal excitability as a biomarker of myofascial pain syndrome. ( 29392210 )
2017
46
Myofascial Pain Syndrome on Tc99m MDP Bone Scintigraphy. ( 28680220 )
2017
47
Comparison between ultrasound-guided interfascial pulsed radiofrequency and ultrasound-guided interfascial block with local anesthetic in myofascial pain syndrome of trapezius muscle. ( 28151904 )
2017
48
Pathophysiology of Trigger Points in Myofascial Pain Syndrome. ( 28379050 )
2017
49
Reliability of the Upper Trapezius Muscle and Fascia Thickness and Strain Ratio Measures by Ultrasonography and Sonoelastography in Participants With Myofascial Pain Syndrome. ( 29276464 )
2017
50
Validity and Reliability of Clinical Examination in the Diagnosis of Myofascial Pain Syndrome and Myofascial Trigger Points in Upper Quarter Muscles. ( 29253210 )
2017
Sources

Variations for Myofascial Pain Syndrome

About this section
Sources

Expression for Myofascial Pain Syndrome

About this section
Search GEO for disease gene expression data for Myofascial Pain Syndrome.
Sources

Pathways for Myofascial Pain Syndrome

About this section
Sources

GO Terms for Myofascial Pain Syndrome

About this section

Biological processes related to Myofascial Pain Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 neuropeptide signaling pathway GO:0007218 9.16 POMC TAC1
2 transmembrane receptor protein tyrosine kinase signaling pathway GO:0007169 8.96 BDNF PDGFRB
3 regulation of blood pressure GO:0008217 8.62 POMC TAC1

Molecular functions related to Myofascial Pain Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 signaling receptor binding GO:0005102 8.62 PDGFRB POMC
Sources

Sources for Myofascial Pain Syndrome

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....